85 related articles for article (PubMed ID: 29043399)
1. Correlation of Somatostatin Receptor-2 Expression with Gallium-68-DOTA-TATE Uptake in Neuroblastoma Xenograft Models.
Zhang L; Vines DC; Scollard DA; McKee T; Komal T; Ganguly M; Do T; Wu B; Alexander N; Vali R; Shammas A; Besanger T; Baruchel S
Contrast Media Mol Imaging; 2017; 2017():9481276. PubMed ID: 29097943
[TBL] [Abstract][Full Text] [Related]
2. Emerging and investigational therapies for neuroblastoma.
Applebaum MA; Desai AV; Glade Bender JL; Cohn SL
Expert Opin Orphan Drugs; 2017; 5(4):355-368. PubMed ID: 29062613
[TBL] [Abstract][Full Text] [Related]
3. The neuroendocrine phenotype, genomic profile and therapeutic sensitivity of GEPNET cell lines.
Hofving T; Arvidsson Y; Almobarak B; Inge L; Pfragner R; Persson M; Stenman G; Kristiansson E; Johanson V; Nilsson O
Endocr Relat Cancer; 2018 Mar; 25(3):367-380. PubMed ID: 29444910
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical assessment and clinical, histopathologic, and molecular correlates of membranous somatostatin type-2A receptor expression in high-risk pediatric central nervous system tumors.
Lazow MA; Fuller C; Trout AT; Stanek JR; Reuss J; Turpin BK; Szabo S; Salloum R
Front Oncol; 2022; 12():996489. PubMed ID: 36465400
[TBL] [Abstract][Full Text] [Related]
5. A Phase II Trial of a Personalized, Dose-Intense Administration Schedule of
Sundquist F; Georgantzi K; Jarvis KB; Brok J; Koskenvuo M; Rascon J; van Noesel M; Grybäck P; Nilsson J; Braat A; Sundin M; Wessman S; Herold N; Hjorth L; Kogner P; Granberg D; Gaze M; Stenman J
Front Pediatr; 2022; 10():836230. PubMed ID: 35359899
[TBL] [Abstract][Full Text] [Related]
6. Impact of cyclic changes in pharmacokinetics and absorbed dose in pediatric neuroblastoma patients receiving [
Malcolm JC; Falzone N; Gains JE; Aldridge MD; Mirando D; Lee BQ; Gaze MN; Vallis KA
EJNMMI Phys; 2022 Mar; 9(1):24. PubMed ID: 35347483
[TBL] [Abstract][Full Text] [Related]
7. p53-Mediated Radiosensitization of
Lundsten S; Berglund H; Jha P; Krona C; Hariri M; Nelander S; Lane DP; Nestor M
Biomolecules; 2021 Nov; 11(11):. PubMed ID: 34827693
[TBL] [Abstract][Full Text] [Related]
8. Nuclear Medicine Imaging in Neuroblastoma: Current Status and New Developments.
Samim A; Tytgat GAM; Bleeker G; Wenker STM; Chatalic KLS; Poot AJ; Tolboom N; van Noesel MM; Lam MGEH; de Keizer B
J Pers Med; 2021 Apr; 11(4):. PubMed ID: 33916640
[TBL] [Abstract][Full Text] [Related]
9. Integrated Microarray to Identify the Hub miRNAs and Constructed miRNA-mRNA Network in Neuroblastoma Via Bioinformatics Analysis.
Chen B; Hua Z; Qin X; Li Z
Neurochem Res; 2021 Feb; 46(2):197-212. PubMed ID: 33104965
[TBL] [Abstract][Full Text] [Related]
10. Personalisation of Molecular Radiotherapy through Optimisation of Theragnostics.
Davis L; Smith AL; Aldridge MD; Foulkes J; Peet C; Wan S; Gains JE; Bomanji JB; Gaze MN
J Pers Med; 2020 Oct; 10(4):. PubMed ID: 33081161
[TBL] [Abstract][Full Text] [Related]
11. Exploring Tumor Heterogeneity Using PET Imaging: The Big Picture.
Bailly C; Bodet-Milin C; Bourgeois M; Gouard S; Ansquer C; Barbaud M; Sébille JC; Chérel M; Kraeber-Bodéré F; Carlier T
Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31480470
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical evaluation of molecular radiotherapy target expression in neuroblastoma tissue.
Gains JE; Sebire NJ; Moroz V; Wheatley K; Gaze MN
Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):402-411. PubMed ID: 29043399
[TBL] [Abstract][Full Text] [Related]
13. 68Ga-DOTATATE and 123I-mIBG as imaging biomarkers of disease localisation in metastatic neuroblastoma: implications for molecular radiotherapy.
Gains JE; Aldridge MD; Mattoli MV; Bomanji JB; Biassoni L; Shankar A; Gaze MN
Nucl Med Commun; 2020 Nov; 41(11):1169-1177. PubMed ID: 32796449
[TBL] [Abstract][Full Text] [Related]
14. Review: The Role of Radiolabeled DOTA-Conjugated Peptides for Imaging and Treatment of Childhood Neuroblastoma.
Alexander N; Vali R; Ahmadzadehfar H; Shammas A; Baruchel S
Curr Radiopharm; 2018; 11(1):14-21. PubMed ID: 29243585
[TBL] [Abstract][Full Text] [Related]
15. 177Lu-DOTATATE molecular radiotherapy for childhood neuroblastoma.
Gains JE; Bomanji JB; Fersht NL; Sullivan T; D'Souza D; Sullivan KP; Aldridge M; Waddington W; Gaze MN
J Nucl Med; 2011 Jul; 52(7):1041-7. PubMed ID: 21680680
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and Clinical Correlations of Somatostatin Receptor-2 (SSTR2) Expression in Neuroblastoma.
Alexander N; Marrano P; Thorner P; Naranjo A; Van Ryn C; Martinez D; Batra V; Zhang L; Irwin MS; Baruchel S
J Pediatr Hematol Oncol; 2019 Apr; 41(3):222-227. PubMed ID: 30334904
[TBL] [Abstract][Full Text] [Related]
17. Pediatric applications of Dotatate: early diagnostic and therapeutic experience.
McElroy KM; Binkovitz LA; Trout AT; Czachowski MR; Seghers VJ; Lteif AN; States LJ
Pediatr Radiol; 2020 Jun; 50(7):882-897. PubMed ID: 32495176
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
